Impact of <scp>COVID</scp> ‐19 Restrictions on Nationwide Antipsychotic Use: Results From the Trends in Drug Utilization During <scp>COVID</scp> ‐19 Pandemic in Turkey ( <scp>PANDUTI</scp> ‐ <scp>TR</scp> ) Study
Our study revealed an upsurge in antipsychotic utilization in Turkey with the start of the pandemic. A range of factors may have contributed, notably the impact of policies facilitating the dispensing of chronic medications without prescription or a tendency towards polypharmacy.
Authors
- Hakan Yılmaz (ORCID: https://orcid.org/0000-0002-1478-3937)
- Ahmet Akici
- Caner Vizdiklar
- Volkan Aydin
Institutions
- Antalya Eğitim ve Araştırma Hastanesi (TR)
- Marmara University (TR)
- Pharmaceuticals and Medical Devices Agency (JP)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1002/pds.70336
- Primary Topic
- COVID-19 and Mental Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00